Researchers have discovered that some osteoporosis drugs that are commonly prescribed by doctors may actually cause serious bone problems. The scientists studying these medications – including Fosomax, Actonel, Boniva, and Reclast – say that the medicines may cause patients to break a bone. Increased fractures of a thigh bone have been identified in women who take these medications for a long time. Patient advocates say that this is very concerning because these patients are specifically being given the drugs in order to improve their bone health. In fact, the patients who are prescribed the medications are already at risk for bone problems and can’t afford to take a medicine that may worsen the problem or even add a new problem. Studies are continuing but some public health workers wonder why the medications are still being marketed and sold with little to no warnings about the current research and risks. They say that when consumer health is at risk the drug makers and doctors have a responsibility to discuss these serious risks with unsuspecting consumers. A medical malpractice lawyer in New York points out that drug manufacturers and doctors who do not warn and discuss these dangers with their patients are acting negligent. This type of negligence can quickly lead to a medical malpractice lawsuit. A negligent drug company or negligent doctor can be held responsible if their patient suffers without having been given all relevant risks, side effects and options. The U.S. Food and Drug Administration (FDA) is the primary governmental organization responsible to decide if the medications should be recalled and pulled off of pharmacy shelves. Catch more on the possible health risks and research on current osteoporosis medicines here.